IL6 and colorectal cancer: The limited metabolic influence of IL-6 on the RPE is surprising given that IL-6 treatment has been shown to promote both glucose uptake and lactate efflux in skeletal muscle cells [29], adipocytes [28], and colorectal cancer cells [30].